Cat. No. 4545
Chemical Name: (2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-m
Biological ActivityInhibitor of cathepsins B and L; also thought to inhibit calpain. Inhibits lysosomal proteases and interferes with autolysosomal digestion when used in combination with pepstatin A (Cat. No. 1190). Lysosome and cell permeable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Wilcox and Mason (1992) Inhibition of cysteine proteinases in lysosomes and whole cells. Biochem.J. 285 495. PMID: 1637341.
Tanada et al (2005) Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1 84. PMID: 16874052.
Sato et al (2007) Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res. 67 9677. PMID: 17942897.
Kim et al (2008) Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4 659. PMID: 18424912.
If you know of a relevant citation for this product please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: E 64d, supplier, lysosomal, proteases, inhibitors, cathepsins, autophagy, autolysosomal, digestion, E64d, Tocris Bioscience, Cathepsin Inhibitors
Find multiple products by catalog number
New Products in this Area
Highly potent and selective renin inhibitorTiplaxtinin
Plasminogen activator inhibitor-1 (PAI-1) inhibitorBalicatib
Potent and selective cathepsin K inhibitorHFI 142
Insulin-regulated aminopeptidase (IRAP) inhibitor
March 14 - 16, 2016
New Orleans, LA, USA